Cannabis Law Report

JANUARY 7, 2020

With our recent event in Cape Town, we have now brought CannaTech to every continent and helped build the cannabis footprint across the world. PsychedeliTech is our newest “Incubaby” designed to create a global ecosystem to accelerate psychedelic innovation by investing in research, education and clinical trials.

Events 59

Events Clinical Trials Decriminalization Education 59

The Cannigma

MAY 19, 2021

While many countries around the world have legalized or decriminalized cannabis or have eased up on enforcement in recent years, in Japan in 2018 there was a sharp increase in cannabis-related arrests — and 80% of them were possession charges. That could potentially change in the near future, however. The future of weed legalization in Japan.

Law 145

Law Legalization Clinical Trials CBD 145

Cannabis Law Report

JULY 9, 2021

federal law, despite this prohibition, a limited number of states have either sought to decriminalize or authorize the medical use of certain psychedelic drugs and substances in limited circumstances. While the medical and adult use of certain psychedelic drugs and substances are generally prohibited under U.S.

Data 105

Data Clinical Trials Decriminalization Hemp 105

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. cities and the State of Oregon have decriminalized them, and last November, Oregon voters legalized the supervised administration of psilocybin. Background. Due to their therapeutic and commercial potential, the U.S.

Law 59

Law Policy Research and Development Clinical Trials 59

SpeedWeed

JULY 6, 2021

The US Food and Drug Administration is also currently sponsoring clinical trials that could lead to the federal legalization of psilocybin- and MDMA -assisted therapy within the next two years. The project also intends to advance research into how psychedelics can heal trauma and how to ensure equitable access to these therapies.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

Cannabis Law Report

MARCH 2, 2020

In lockstep with the FDA’s more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms. This renewed interest in psychedelics is being sparked by a pair of seemingly unrelated events. Hundreds of other U.S. The dawn of a new era in psychedelic medicine.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59